Thermo Fisher to help manufacture Moderna’s COVID-19 vaccine

Thermo Fisher signed an agreement to provide fill and finish manufacturing for “hundreds of millions of doses” of Moderna’s COVID-19 vaccine, the drugmakers announced June 1.

Advertisement

Beginning in the third quarter of 2021, Thermo Fisher will produce Moderna’s vaccine using its manufacturing plant in Greenville, N.C. 

Moderna has contracted other drugmakers to boost its COVID-19 vaccine production, including deals made in April with Sanofi and Catalent.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.